Gibson Dunn Advises Concentra Biosciences on Acquisition of CARGO Therapeutics, Inc.
Dan Mulloy
Gibson Dunn is representing Concentra Biosciences, an affiliate of Tang Capital Management, on its acquisition of CARGO Therapeutics, Inc. (Nasdaq: … The post Gibson Dunn Advises Concentra Biosciences on Acquisition of CARGO Therapeutics, Inc. appeared first on Gibson Dunn .